USPTO serial 79346303
Serial No. 79346303
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 23, 2024
- Examiner
- LAWRENCE, SUSAN KASTRINER
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with Serial No. 79346303?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Cinclus Pharma Holding AB (publ)
SE
CH
CH
CH
CH
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Charles P. Guarino
Charles P. Guarino Moser Taboada1040 Broad Street - Suite 103Shrewsbury, NJ 07702UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and substances for the treatment of gastrointestinal diseases and disorders; medicinal preparations and substances for the treatment of gastrointestinal diseases and disorders; pharmaceuticals for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for treating gastrointestinal disorders; medicines for the treatment of gastrointestinal diseases | ACTIVE | — |
| 042 | Development of pharmaceutical preparations and medicines; pharmaceutical drug development services; scientific research in the field of pharmaceuticals; scientific research and development; pharmaceutical products development; medical research | ACTIVE | — |
| 044 | Medical services; healthcare advisory services; pharmaceutical advice; advisory services relating to pharmaceuticals; medical counseling | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Cinclus Pharma Holding AB (publ)
- Other trademarks owned by Cinclus Pharma AG
- Other trademarks owned by Cinclus Pharma AG
- Other trademarks owned by Cinclus Pharma AG
- Other trademarks owned by Cinclus Pharma AG
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 30, 2026 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| May 13, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 24, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 24, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 23, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 23, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 23, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 22, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 3, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 3, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Nov 7, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 7, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 6, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 18, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 18, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 18, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 2, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 28, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 28, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 28, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 18, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 1, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 1, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 4, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 3, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 1, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 2, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 29, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 28, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |